White Owl Capital Partners

Brim Financial Inc., established in Toronto, Canada in 2015, specializes in issuing non-banking credit cards. The company offers a range of card types including reward cards, travel cards, and standard credit cards, all designed to enhance users' payment experiences. Brim's platform stands out with features such as embedded plans, custom security measures, unlimited rewards programs, digital installment plans, and real-time monetary advisory services accessible via an in-app digital portal. Formerly known as KREDITShare Inc., the company rebranded to Brim Financial Inc. in September 2017.

BESE Inc is a digital media company based in Los Angeles, California, that specializes in creating multi-format cultural storytelling. Established in 2017, the company focuses on broadening and reshaping cultural narratives through its platform, which provides digital news content and allows the sharing of untold stories relevant to diverse cultures and nations. Targeting millennial and Gen-Z audiences, BESE distributes its stories across various social and digital platforms, ensuring seamless access to information and fostering community engagement.

Lola Lola operates as cannabis company. They serves to elevate the cannabis movement by creativity, connectivity, and community. They make all of their products as ethically and sustainably as possible, and to infuse every bud with heart-centered intentions.

Founded in 2011, TurnCare specializes in developing innovative patient support systems designed to prevent and treat pressure injuries. Its flagship product, the Q2 System, uses advanced technology to monitor chamber pressures and adjust pressure application, promoting healthy movement and recovery for mobility-impaired patients.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, focused on innovating blood collection practices to enhance patient care and reduce associated risks. Founded in 2011, the company has developed the PIVO device, a needle-free and single-use sterile tool designed to draw blood from indwelling peripheral IV lines. This device aims to minimize the number of needle sticks and central line access required for blood collection. By enabling frequent and high-quality blood draws, the PIVO device seeks to deliver a more compassionate and efficient healthcare experience for hospital inpatients while also providing a safer solution for healthcare providers. Velano Vascular is dedicated to addressing the challenges of vascular access and improving the overall efficiency of blood collection in clinical settings.

Mass Appeal Media, Inc. is a multifaceted media company that produces and develops documentaries, scripted series, and unscripted formats for the film and television industry. Founded in 1996 and headquartered in New York, it has evolved from its origins as a graffiti magazine into a prominent publisher of urban lifestyle content. The company creates and publishes music, digital video, and editorial content, while also specializing in the production of premium advertising and branded content. Mass Appeal designs and executes marketing campaigns for global brands, reflecting a rich cultural heritage that spans music, art, and fashion. Its unique perspective aims to document the cultural convergence of these elements, engaging opinion leaders and trendsetters in contemporary conversations.

AdvisorConnect is a platform designed to accelerate sales for financial advisors and insurance agents. It uses AI-driven technology to automate workflows, analyze network data in real-time, and facilitate strategic decision-making in product marketing and content.

DotAlign is a Manhattan-based software company that delivers a cloud‑based relationship intelligence platform. By automatically extracting data from email, calendar, contacts, LinkedIn, and CRM systems, it measures the strength of internal and external relationships and provides actionable insights such as who knows whom, who is most reachable, and which contacts are falling out of touch. The platform integrates this knowledge into everyday productivity tools like Outlook and CRM workflows, helping users identify the most effective colleagues and contacts for introductions or follow‑ups. Founded in 2009 as OpSpark, the company rebranded to DotAlign in 2012 and has raised $1.6 million in 2015. It primarily serves investment banks and private‑equity firms.

Dosist is a health and wellness company that specializes in developing proprietary vaporizing dose-pens designed to deliver safe and effective cannabis-based therapies. Founded in 2016 in California, Dosist initially operated under the name "hmbldt" before relocating to Los Angeles. The company focuses on providing precise, dose-controlled cannabis solutions for adults aged 21 and older, emphasizing the importance of dosage in their product development. Through its innovative precision wellness technology, Dosist enables users to experience the benefits of cannabinoid-based therapy in a consistent and predictable manner. The company has received recognition for its contributions to the industry, including being named one of TIME Magazine's Top 25 Inventions of 2016 and a finalist for the Fast Company World Changing Ideas Awards.

Vigilant Biosciences, Inc. is a medical technology company headquartered in Fort Lauderdale, Florida, specializing in the early detection and intervention of oral cancer. Founded in 2011, the company develops non-invasive screening solutions that empower healthcare practitioners to improve patient outcomes. Its product line, including the OncAlert Oral Cancer RAPID Test and the OncAlert Labs OraMark Test, utilizes patented technology to measure specific biomarkers associated with oral cancer in a simple, oral rinse procedure. These tests are designed to be accurate, cost-effective, and easy to administer, enabling healthcare professionals to identify cancer in its early stages, well before any visual or physical symptoms manifest. Vigilant Biosciences aims to enhance health by facilitating early intervention and potentially altering adverse health outcomes related to oral cancer.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, focused on innovating blood collection practices to enhance patient care and reduce associated risks. Founded in 2011, the company has developed the PIVO device, a needle-free and single-use sterile tool designed to draw blood from indwelling peripheral IV lines. This device aims to minimize the number of needle sticks and central line access required for blood collection. By enabling frequent and high-quality blood draws, the PIVO device seeks to deliver a more compassionate and efficient healthcare experience for hospital inpatients while also providing a safer solution for healthcare providers. Velano Vascular is dedicated to addressing the challenges of vascular access and improving the overall efficiency of blood collection in clinical settings.

Vigilant Biosciences, Inc. is a medical technology company headquartered in Fort Lauderdale, Florida, specializing in the early detection and intervention of oral cancer. Founded in 2011, the company develops non-invasive screening solutions that empower healthcare practitioners to improve patient outcomes. Its product line, including the OncAlert Oral Cancer RAPID Test and the OncAlert Labs OraMark Test, utilizes patented technology to measure specific biomarkers associated with oral cancer in a simple, oral rinse procedure. These tests are designed to be accurate, cost-effective, and easy to administer, enabling healthcare professionals to identify cancer in its early stages, well before any visual or physical symptoms manifest. Vigilant Biosciences aims to enhance health by facilitating early intervention and potentially altering adverse health outcomes related to oral cancer.

Velano Vascular, Inc. is a medical device company based in San Francisco, California, focused on innovating blood collection practices to enhance patient care and reduce associated risks. Founded in 2011, the company has developed the PIVO device, a needle-free and single-use sterile tool designed to draw blood from indwelling peripheral IV lines. This device aims to minimize the number of needle sticks and central line access required for blood collection. By enabling frequent and high-quality blood draws, the PIVO device seeks to deliver a more compassionate and efficient healthcare experience for hospital inpatients while also providing a safer solution for healthcare providers. Velano Vascular is dedicated to addressing the challenges of vascular access and improving the overall efficiency of blood collection in clinical settings.

Mass Appeal Media, Inc. is a multifaceted media company that produces and develops documentaries, scripted series, and unscripted formats for the film and television industry. Founded in 1996 and headquartered in New York, it has evolved from its origins as a graffiti magazine into a prominent publisher of urban lifestyle content. The company creates and publishes music, digital video, and editorial content, while also specializing in the production of premium advertising and branded content. Mass Appeal designs and executes marketing campaigns for global brands, reflecting a rich cultural heritage that spans music, art, and fashion. Its unique perspective aims to document the cultural convergence of these elements, engaging opinion leaders and trendsetters in contemporary conversations.